Regular Article
Structural Heterogeneity of Caucasian N-Acetyltransferase at the NAT1 Gene Locus

https://doi.org/10.1006/abbi.1993.1116Get rights and content

Abstract

The human N-acetylation polymorphism is a genetic trait phenotypically reflected by differences in N-acetyltransferase (NAT) activity with therapeutic agents (rapid and slow acetylation), but a genetic invariability in N-acetylation of some arylamine drugs is also known. There are two highly similar human NAT genes: NAT1 is thought to encode a genetically invariant protein, whereas NAT2 has conclusively been shown to represent a polymorphic locus. This study demonstrates the presence of discrete NAT1 structural variants among Caucasians. These were detected by direct sequencing of 1.6-kilobase NAT1 fragments generated by the polymerase chain reaction with liver and leukocyte DNA from 13 subjects of established acetylator phenotype and NAT2 genotype. A prominent alteration in one of the variants was obliteration of the consensus polyadenylation signal (AATAAA→AAAAAA). Several mutations were discernible in all regions of the second variant allele, including silent (codon 153) and nonsilent (Ser-214→Ala) substitutions in the coding region and deletion of nine bases from an AT-rich segment in the 3′ untranslated region. One-half of the unrelated subjects were either homozygous or heterozygous for the mutant NAT1 alleles, both of which obeyed a Mendelian inheritance pattern. These novel results unambiguously show that human NAT1, like NAT2, is a polymorphic locus.

References (0)

Cited by (165)

  • Genetic polymorphism of NAT1 in local Pakistani population

    2021, Gene Reports
    Citation Excerpt :

    Many studies have demonstrated that NAT1 genetic polymorphism is related to a predisposition to numerous cancers from heterocyclic amine carcinogens and arylamines (Doll and Hein, 2002). The NAT1 gene polymorphism was firstly described two decades ago (Vatsis and Weber, 1993), and the identified alleles in human populations were almost 26; NAT1*3, NAT1*4, NAT1*10 and NAT1*11 being the most prevalent alleles reported. A single mutation (SNP) or a combination of multiple nucleotide substitutions and insertions/deletions are responsible for the allelic variants of NAT1.

  • Arylamine N-Acetyltransferases

    2018, Comprehensive Toxicology: Third Edition
  • Structural and functional effects of nucleotide variation on the human TB drug metabolizing enzyme arylamine N-acetyltransferase 1

    2017, Journal of Molecular Graphics and Modelling
    Citation Excerpt :

    Since human NAT1 plays a vital role in detoxification and potential metabolic activation of xenobiotic compounds, it is important in clinical pharmacology and toxicology. Previous research has shown non-synonymous single nucleotide polymorphisms (nsSNPs) in the genomic DNA sequence of human NAT1 that imply changes in its amino acid sequence [10–14]. This has the potential to destabilize the enzyme structure and negatively affect the function of the NAT1 enzyme.

  • Arylamine N-acetyltransferases

    2010, Comprehensive Toxicology, Second Edition
  • Antioxidant enzymes, presbycusis, and ethnic variability

    2010, Otolaryngology - Head and Neck Surgery
    Citation Excerpt :

    The resulting 369-bp (primers set A) and 547-bp (primers set B) PCR products were subjected to RFLP analysis and the primer sequences provided as requested. The presence or absence of the T341C nucleotide substitution was detected by use of the allele-specific PCR method described by Vatsis and Weber.14 G191A, C282T, C341T, C480T, G590A, and G857 substitutions were confirmed by direct sequencing on an automated sequencer (ABI 3100).

  • The Role of Drug Metabolism in Toxicity

    2022, DRUG METABOLISM HANDBOOK: CONCEPTS AND APPLICATIONS IN CANCER RESEARCH
View all citing articles on Scopus
View full text